KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Interest & Investment Income: 2018-2024

Historic Interest & Investment Income for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to $12.9 million.

  • Castle Biosciences' Interest & Investment Income fell 16.77% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.2 million, marking a year-over-year decrease of 3.28%. This contributed to the annual value of $12.9 million for FY2024, which is 21.59% up from last year.
  • Latest data reveals that Castle Biosciences reported Interest & Investment Income of $12.9 million as of FY2024, which was up 21.59% from $10.6 million recorded in FY2023.
  • Castle Biosciences' Interest & Investment Income's 5-year high stood at $12.9 million during FY2024, with a 5-year trough of $68,000 in FY2021.
  • In the last 3 years, Castle Biosciences' Interest & Investment Income had a median value of $10.6 million in 2023 and averaged $9.2 million.
  • In the last 5 years, Castle Biosciences' Interest & Investment Income slumped by 81.77% in 2021 and then spiked by 5,735.29% in 2022.
  • Over the past 5 years, Castle Biosciences' Interest & Investment Income (Yearly) stood at $373,000 in 2020, then slumped by 81.77% to $68,000 in 2021, then surged by 5,735.29% to $4.0 million in 2022, then surged by 167.72% to $10.6 million in 2023, then increased by 21.59% to $12.9 million in 2024.